AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|
16.7 C
New York
Monday, October 26, 2026

Tag: conference

Global Times: Pursuing the path of financial development with Chinese characteristics

BEIJING, June 24, 2025 /PRNewswire/ -- Finance is the core of the modern economy and the lifeblood of national economy.From the concept of "the...

Genprex Collaborators Present Positive Preclinical Research on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions

Latest Research Demonstrates Promising Improved Glucose Homeostasis by Reprogramming Alpha Cells AUSTIN, Texas, June 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...

Sunrise Realty Trust Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 7th, 2025 before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

NTW 2025 SETS RECORD WITH 3.5 MILLION PARTICIPANTS UNDER MALAYSIA’S LEADERSHIP OF AYOS 2025

KUALA LUMPUR, Malaysia, June 24, 2025 /PRNewswire/ -- National Training Week (NTW) 2025 concluded with a groundbreaking 3.5 million participants, underscoring the region's growing...

Ceva Launches MotionEngine™ Hex: Bringing Precise, Touch-Free, Spatial Control to Smart TV, Gaming, and IoT Interfaces

MotionEngine Hex software fuses UWB and motion sensor data to deliver 6-degree-of-freedom (6-DOF) motion tracking and intuitive control, enabling new interaction paradigms for electronic displays ROCKVILLE,...

The SIP Forum Opens Registration for SIPNOC 2025 – The 14th Annual SIP Network Operators Conference

SIPNOC 2025 - "The Gathering Place for the Call Authentication Community" - is focused the broad Call and Text Authentication ecosystem and the continuing...

Tims China Announces First Quarter 2025 Financial Results

System Sales Increased 3.5% Year-over-Year to RMB376.3 Million

Docugami Expands to Europe with New Subsidiary based in France to Advance Open and Sovereign Document AI

Paris, June 24, 2025 — Docugami, the fast-growing U.S. startup specializing in Document AI, announces the launch of Docugami Europe, its new subsidiary based in France. This move marks a strategic investment in the European innovation landscape and reinforces Docugami’s commitment to advancing open, transparent, and sovereign AI.

Silent No More: Protesters Demand Consumer Voice at Tobacco Control Summit

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- On the opening day of the World Conference on Tobacco Control (WCTC) in Dublin, the World Vapers’ Alliance staged a silent protest outside the venue, visually highlighting the exclusion of consumers from global tobacco and nicotine policy debates. Demonstrators with their mouths taped symbolised the ongoing marginalisation of those most affected by regulatory decisions.

FinVolution Announces Global AI Competition Targeting Deepfake Risks

SHANGHAI, June 24, 2025 /PRNewswire/ -- FinVolution Group has officially launched the 2025 FinVolution Global Data Science Competition today, with a spotlight on deepfake...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, Bitfarms, and Reddit and Encourages Investors to Contact...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSE: UNH), Bitfarms Ltd. (NASDAQ: BITF), and Reddit, Inc. (NYSE:RDDT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsConference